Notes on the pathogenesis of human immunodeficiency virus infection. 1997

S Piconi, and M Clerici
Prima Divisione di Malattie Infettive, Università degli Studi, Milan, Italy.

The acquired immunodeficiency syndrome (AIDS) is a clinically multifaceted disease induced by infection with the human immunodeficiency virus (HIV). Infection with HIV is usually followed by a period of clinical latency which is followed by development of AIDS and death. The factors that influence the evolution of HIV infection, and therefore determine the natural history of the disease in each patient are currently unknown, but the profound dysregulation of immunity characteristic of HIV infection is likely to play a pivotal role in determining the outcome of the disease. Thus, the complex interplay between two different factors, HIV itself and the immune response to the virus, is at the basis of the disease. In this brief review we will summarize the evidences indicating that HIV infection is a virus-induced and mainly immunologically mediated disease.

UI MeSH Term Description Entries
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

S Piconi, and M Clerici
January 1994, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
S Piconi, and M Clerici
January 1989, Annals of the New York Academy of Sciences,
S Piconi, and M Clerici
March 1993, Microbiological reviews,
S Piconi, and M Clerici
January 1988, Gene analysis techniques,
S Piconi, and M Clerici
July 1987, The New England journal of medicine,
S Piconi, and M Clerici
March 1999, The British journal of nutrition,
S Piconi, and M Clerici
October 1990, Vnitrni lekarstvi,
S Piconi, and M Clerici
January 1988, Srpski arhiv za celokupno lekarstvo,
S Piconi, and M Clerici
May 2001, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
S Piconi, and M Clerici
March 1991, The Pediatric infectious disease journal,
Copied contents to your clipboard!